On Monday, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) opened higher 13.30% from the last session, before settling in for the closing price of $17.44. Price fluctuations for SNDX have ranged from $8.58 to $18.00 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -15.16%. Company’s average yearly earnings per share was noted 16.90% at the time writing. With a float of $84.26 million, this company’s outstanding shares have now reached $86.91 million.
Syndax Pharmaceuticals Inc (SNDX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Syndax Pharmaceuticals Inc is 3.05%, while institutional ownership is 115.79%. The most recent insider transaction that took place on Sep 08 ’25, was worth 2,582,021. In this transaction Chief Executive Officer of this company sold 157,307 shares at a rate of $16.41, taking the stock ownership to the 298,661 shares. Before that another transaction happened on Sep 08 ’25, when Company’s Director proposed sale 157,307 for $17.04, making the entire transaction worth $2,680,511.
Syndax Pharmaceuticals Inc (SNDX) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.1 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.23) by -0.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Trading Performance Indicators
Check out the current performance indicators for Syndax Pharmaceuticals Inc (SNDX). In the past quarter, the stock posted a quick ratio of 4.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.62, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -1.70 in one year’s time.
Technical Analysis of Syndax Pharmaceuticals Inc (SNDX)
The latest stats from [Syndax Pharmaceuticals Inc, SNDX] show that its last 5-days average volume of 2.59 million was superior to 2.39 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 79.21%.
During the past 100 days, Syndax Pharmaceuticals Inc’s (SNDX) raw stochastic average was set at 98.07%, which indicates a significant increase from 96.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.23 in the past 14 days, which was higher than the 0.86 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.47, while its 200-day Moving Average is $13.12. Now, the first resistance to watch is $20.50. This is followed by the second major resistance level at $21.25. The third major resistance level sits at $22.51. If the price goes on to break the first support level at $18.49, it is likely to go to the next support level at $17.23. The third support level lies at $16.48 if the price breaches the second support level.
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) Key Stats
There are currently 86,915K shares outstanding in the company with a market cap of 1.72 billion. Presently, the company’s annual sales total 23,680 K according to its annual income of -318,760 K. Last quarter, the company’s sales amounted to 45,870 K and its income totaled -60,720 K.
